Ayala Pharmaceuticals Inc (ADXS)

[cdiddy01]

I stand corrected. Going concern doubts should be evaluated on all financial statement disclosures. I incorrectly tied it to their annual audit report from their independent external auditors.

Likewise, this was on ADXS 10-K: Disclosures of Uncertainties About an Entity’s Ability to Continue as a Going Concern. The new standard provides guidance around management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. The new standard is effective for fiscal years, and interim periods within those fiscal years. The Company has adopted this standard effective for the year ending October 31, 2017.